During the past decade, Schuster Medical Research Institute conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schuster Medical Research Institute" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Karuna Therapeutics" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schuster Medical Research Institute" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator, "Neumora Therapeutics, Inc." with 1 trials as a collaborator and "Otsuka America Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Schuster Medical Research Institute" are "Schizophrenia" (8 trials), "Alzheimer's Disease" (5 trials), "Depression" (4 trials), "Depressive Disorder, Major" (3 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Schuster Medical Research Institute" in a lesser frequency.

Most popular intervention types in "Schuster Medical Research Institute" are "Drug" (29 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials), "BMS-820836" (2 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Schuster Medical Research Institute" are 27 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Schuster Medical Research Institute". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Schuster Medical Research Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Schuster Medical Research Institute, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".